As of 2025-05-17, the Fair Value of Concert Pharmaceuticals Inc (CNCE) is -59.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.37 USD, the upside of Concert Pharmaceuticals Inc is -815.55%.
With the market price of 8.37 USD and our fair value calculation, Concert Pharmaceuticals Inc (CNCE) is not a good investment. Investing in CNCE stocks now will result in a potential loss of 815.55%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | 95.60 | -56.00 | -78.20 | -74.80 | -80.05 | -38.69 |
| YoY growth | 288.56% | -158.58% | -39.64% | 4.35% | -7.02% | 17.53% |
| Market Cap (mil) | 401.95 |
| P/E | |
| Forward P/E | -2.50x |
| EPS | -3.42 |
| Avg earnings growth rate | 17.53% |
| TTM earnings | -164.04 |